Back to results
US 2014/0275140 A1Published application
Method and products for enhancing drug and dietary supplement bioavailability
AssigneeCBA Pharma, Inc.
InventorDaryl L. Barnett
Life of this patent
Estimating the term…
Abstract
Enhancing the bioavailability of a drug or dietary supplement by administering it concurrently with one or more members of the d-tetrandrine family.
Claims20
A method of enhancing the bioavailability of drugs and dietary supplements comprising:
- the concurrent administration of a drug or dietary supplement and a member of the d-tetrandrine family of drugs having the following structural formula:
- where R1 and R1′ are the same or different short chained carbon based ligand including without limitation, CH3, CO2CH3 or H;
- and R2 is CH3 or C2H5;
- and R3 is CH3 or hydrogen, and wherein said structural formula has the “S” isomeric configuration at the C-1′ chiral carbon location.
1 more element
A dietary supplement composition comprising a dietary supplement combined with a member of the d-tetrandrine family having the following structural formula:
- where R1 and R1′ are the same or different short chained carbon based ligand including without limitation, CH3, CO2CH3 or H;
- and R2 is CH3 or C2H5;
- and R3 is CH3 or hydrogen, and wherein said structural formula has the “S” isomeric configuration at the C-1′ chiral carbon location.
A kit including a dietary supplement, and a formulation comprising a member of the d-tetrandrine family having the following structural formula:
- where R1 and R1′ are the same or different short chained carbon based ligand including without limitation, CH3, CO2CH3 or H;
- and R2 is CH3 or C2H5;
- and R3 is CH3 or hydrogen, and wherein said structural formula has the “S” isomeric configuration at the C-1′ chiral carbon location.
Dependencies are inferred from the claim text.